8.05
Xeris Biopharma Holdings Inc Aktie (XERS) Neueste Nachrichten
When is the best time to exit Xeris Biopharma Holdings Inc.Analyst Downgrade & Accurate Buy Signal Alerts - newser.com
Xeris Biopharma Holdings Inc. stock prediction for this weekEarnings Trend Report & Verified Short-Term Trading Plans - newser.com
Beat the Market the Zacks Way: MariMed, Xeris Biopharma, Lam Research in Focus - Yahoo Finance
How to read the order book for Xeris Biopharma Holdings Inc.Bear Alert & Safe Entry Point Identification - newser.com
Risk vs reward if holding onto Xeris Biopharma Holdings Inc.2025 Top Decliners & Reliable Entry Point Alerts - newser.com
Why Xeris Biopharma Holdings Inc. (2B30) stock could be top winnerQuarterly Trade Report & Low Volatility Stock Recommendations - newser.com
Can Xeris Biopharma Holdings Inc. recover in the next quarter2025 Valuation Update & Reliable Momentum Entry Alerts - newser.com
Volume spikes in Xeris Biopharma Holdings Inc. stock – what they meanJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com
What is the fair value estimate for Xeris Biopharma Holdings Inc. (2B30) stock in 2025Weekly Market Summary & Free Safe Entry Trade Signal Reports - newser.com
Analyzing net buyer seller activity in Xeris Biopharma Holdings Inc.IPO Watch & Reliable Intraday Trade Plans - newser.com
Is it time to cut losses on Xeris Biopharma Holdings Inc.2025 Key Highlights & Community Verified Trade Alerts - newser.com
Measuring Xeris Biopharma Holdings Inc.’s beta against major indicesTrade Risk Summary & Free Growth Oriented Trading Recommendations - newser.com
How buyback programs support Xeris Biopharma Holdings Inc. (2B30) stock2025 AllTime Highs & Low Risk Growth Stock Ideas - newser.com
Weiss Ratings Reiterates Sell (D-) Rating for Xeris Biopharma (NASDAQ:XERS) - MarketBeat
Xeris Biopharma (NASDAQ:XERS) Stock Price Down 4%Here's What Happened - MarketBeat
Xeris Biopharma Holdings (XERS): Exploring Valuation as Analysts Grow Bullish on Breakeven Prospects and Earnings Progress - simplywall.st
Xeris Biopharma Reaches New 52-Week High of $8.51, Up 253% - Markets Mojo
News impact scoring models applied to Xeris Biopharma Holdings Inc.Portfolio Value Summary & Growth Focused Stock Pick Reports - newser.com
Xeris Biopharma Holdings Inc.’s volatility index tracking explainedMarket Risk Analysis & Low Risk Investment Opportunities - newser.com
Will Xeris Biopharma Holdings Inc. outperform the marketJuly 2025 Big Picture & AI Enhanced Trading Alerts - newser.com
Will Xeris Biopharma Holdings Inc. stock deliver shareholder valueJuly 2025 Market Mood & Low Drawdown Momentum Ideas - newser.com
Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635c4 - MarketScreener
XERS Back In The Spotlight As Recorlev Surges, Gvoke Steadies, And Keveyis Holds Strong - RTTNews
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Xeris Biopharma's Path Toward Profitability Might Change The Case For Investing In XERS - simplywall.st
Xeris Biopharma (XERS) is a Great Momentum Stock: Should You Buy? - sharewise.com
Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS): Are Analysts Optimistic? - Yahoo Finance
Xeris Biopharma Holdings, Inc. (XERS) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Why Xeris Biopharma Holdings Inc. stock could be next big winnerQuarterly Earnings Summary & Detailed Earnings Play Strategies - newser.com
Why Xeris Biopharma Holdings Inc. (2B30) stock could outperform next yearMarket Movement Recap & AI Enhanced Trading Signals - newser.com
Can Xeris Biopharma Holdings Inc. stock weather global recession2025 Support & Resistance & Daily Profit Focused Stock Screening - newser.com
Published on: 2025-10-03 05:03:07 - newser.com
Leading vs lagging indicators on Xeris Biopharma Holdings Inc. performanceWeekly Profit Summary & Risk Managed Investment Strategies - newser.com
Is Xeris Biopharma Holdings Inc. (2B30) stock supported by strong fundamentalsJobs Report & Free Accurate Trade Setup Notifications - newser.com
Xeris Biopharma (NASDAQ:XERS) Hits New 12-Month HighTime to Buy? - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):